The use of interferon beta in relapsing-remitting multiple sclerosis.
The use of interferon beta-1a to treat multiple sclerosis in a child of 7 years of age is discussed. To date, there is only one other published report of the use of interferon beta in a child as young as this. One year after commencing treatment she had shown significant clinical improvement, with a marked reduction in number of relapses. In her second year of treatment she suffered a major relapse from which she slowly recovered.
Etheridge
L J
LJ
Bradford Royal Infirmary, UK.
Beverley
D W
DW
Ferrie
C
C
McManus
E
E
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D002648:Child; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D005938:Glucocorticoids; D016899:Interferon-beta; D008775:Methylprednisolone; D000068556:Interferon beta-1a